Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy of Ketamine for the Treatment of Concurrent Opioid Use Disorder and Major Depressive Disorder


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04177706

Organisation Name: Medical University of South Carolina

Overal Status: Recruiting

Start Date: December 17, 2020

Last Update: January 11, 2021

Lead Sponsor: Medical University of South Carolina

Brief Summary: The purpose of the study is to examine whether an investigational medication called ketamine is able to improve treatment outcomes for concurrent opioid addiction and depression when used in conjunction with buprenorphine treatment. Study medications will be delivered twice per week for four weeks. If you are eligible and you decide to enroll in the study, your participation will last approximately 8 weeks, or 2 months.

Conditions:
  • Depression
  • Opioid-use Disorder
  • Opioid Abuse


Total execution time in seconds: 0.46130681037903